Literature DB >> 15876554

Nonconvulsive status epilepticus on treatment with levetiracetam.

Ramin Atefy1, Barbara Tettenborn.   

Abstract

In several studies the efficacy and tolerability of levetiracetam (LEV) have been demonstrated. We report two patients who developed nonconvulsive status epilepticus on treatment with LEV. Both patients never experienced status epilepticus before. One patient had a symptomatic epilepsy with complex partial seizures following radiotherapy of astrocytoma in 1985; the second patient had complex partial seizures due to mesial temporal sclerosis. Both patients received LEV 2000 mg/day. We postulate a correlation between occurrence of nonconvulsive status and treatment with LEV. This has not been described before apart from a single report of mentally retarded patients with status epilepticus on high dosages of LEV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876554     DOI: 10.1016/j.yebeh.2005.03.015

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.

Authors:  Nicholas S Abend; Heather M Monk; Daniel J Licht; Dennis J Dlugos
Journal:  Pediatr Crit Care Med       Date:  2009-07       Impact factor: 3.624

2.  Status epilepticus in the elderly: epidemiology, clinical aspects and treatment.

Authors:  Telma M R de Assis; Gersonita Costa; Aroldo Bacellar; Marco Orsini; Osvaldo J M Nascimento
Journal:  Neurol Int       Date:  2012-12-04

3.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.